Brind.
  1. Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.
  2. Collaboration agreements for oncology candidates were signed between several major pharmaceutical companies.

A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.

1 report, 1 independent Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.

Who's involved

What this event is mainly about
Relay TherapeuticsHoffmann-La RocheSanofiRecursion (United States)Merck

How it developed

Newest first. Tap a step to see who reported it.
  1. Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.Sub-event
  2. Collaboration between Recursion, Sanofi, Roche, Merck, and Relay on AI-driven oncology and immunology pipelines.1 source

Keep exploring

Part of

Collaboration agreements for oncology candidates were signed between several major pharmaceutical companies. All 1 developments

Within Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • ZacksCan Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? Recursion Pharmaceuticals RXRX is strategically leveraging its AI-powered drug discovery platform through multiple high-value col